Buscas alternativas:
decrease adhesion » increases adhesion (Expandir a busca), decrease asian (Expandir a busca), decreases aggression (Expandir a busca)
adhesion decrease » adhesin decreases (Expandir a busca), lesions decrease (Expandir a busca), abortion decrease (Expandir a busca)
decrease risk » decreased risk (Expandir a busca), increase risk (Expandir a busca), decrease in (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease can » decrease in (Expandir a busca), decrease and (Expandir a busca), decrease at (Expandir a busca)
can decrease » and decrease (Expandir a busca), can increase (Expandir a busca), to decrease (Expandir a busca)
risk patient » risk patients (Expandir a busca)
decrease adhesion » increases adhesion (Expandir a busca), decrease asian (Expandir a busca), decreases aggression (Expandir a busca)
adhesion decrease » adhesin decreases (Expandir a busca), lesions decrease (Expandir a busca), abortion decrease (Expandir a busca)
decrease risk » decreased risk (Expandir a busca), increase risk (Expandir a busca), decrease in (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease can » decrease in (Expandir a busca), decrease and (Expandir a busca), decrease at (Expandir a busca)
can decrease » and decrease (Expandir a busca), can increase (Expandir a busca), to decrease (Expandir a busca)
risk patient » risk patients (Expandir a busca)
1
Systematic review on determinants of therapeutic adherence in individuals from 50 to 69 years of age
Assuntos:
“...patient compliance...”Acessar documento
Dissertação
2
“... with adverse patient outcomes. Syndecan-1 is a biomarker of endothelial glycocalyx damage and its early...”
Acessar documento
Acessar documento
Tese
3
“... with adverse patient outcomes. Syndecan-1 is a biomarker of endothelial glycocalyx damage and its early...”
Acessar documento
Acessar documento
Tese
4
5